Tsumura forecast consolidated net profit of ¥29.3 billion for the fiscal year ending March 2027, revising up its previous forecast for a 4% year-on-year decline. The company said negative goodwill would arise from making Yomeishu Seizo a subsidiary.
Tsumura announced on the 28th that consolidated net profit for the fiscal year ending March 2027 is likely to be approximately ¥29.3 billion. It indicated that profit is expected to exceed its previous forecast and rise 4% year on year.
The company said negative goodwill is expected to arise in connection with making Yomeishu Seizo a subsidiary.
Yomeishu lists medicinal Yomeishu as its flagship product. The market is watching how the acquisition will contribute to improving ROE and expanding the business.